Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-03-11 @ 4:30 PM
Study NCT ID:
NCT02818920
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-18
First Post:
2016-06-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Pembrolizumab
Sponsor:
Neal Ready MD PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2016-06-28
First Submit QC Date:
None
Study First Post Date:
2016-06-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-02-05
Results First Submit QC Date:
None
Results First Post Date:
2020-02-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-14
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL